Multikinase Inhibition Induces Tumor Microenvironment Remodeling in PDAC
Cancer Discovery
|February 12, 2022
Abstract:
Combination trametinib and nintedanib induces cell death and reprograms the immunosuppressive microenvironment.
Insights
Combination therapy with trametinib and nintedanib promotes cancer cell death. This treatment also reprograms the tumor microenvironment, shifting it away from immunosuppression.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- The tumor microenvironment plays a critical role in cancer progression and immune evasion.
- Targeting specific signaling pathways is a key strategy in cancer therapy.
Purpose of the Study:
- To investigate the combined effects of trametinib and nintedanib on cancer cells.
- To evaluate the impact of this combination on the immunosuppressive tumor microenvironment.
Main Methods:
- In vitro cell culture models.
- Analysis of cell death markers.
- Assessment of immune cell infiltration and cytokine profiles in the tumor microenvironment.
Main Results:
- The combination of trametinib and nintedanib significantly induced cancer cell death.
- Reprogramming of the immunosuppressive microenvironment was observed, with changes in immune cell populations and signaling.
Conclusions:
- Combination therapy with trametinib and nintedanib demonstrates potent anti-cancer activity.
- This combination therapy holds promise for overcoming the immunosuppressive tumor microenvironment in cancer treatment.
Related Concept Videos
01:19Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K
01:10Drugs that Destabilize Microtubules
2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K